298 related articles for article (PubMed ID: 25426797)
1. Synthesis and κ-opioid receptor activity of furan-substituted salvinorin A analogues.
Riley AP; Groer CE; Young D; Ewald AW; Kivell BM; Prisinzano TE
J Med Chem; 2014 Dec; 57(24):10464-75. PubMed ID: 25426797
[TBL] [Abstract][Full Text] [Related]
2. Synthetic studies of neoclerodane diterpenes from Salvia divinorum: preparation and opioid receptor activity of salvinicin analogues.
Simpson DS; Katavic PL; Lozama A; Harding WW; Parrish D; Deschamps JR; Dersch CM; Partilla JS; Rothman RB; Navarro H; Prisinzano TE
J Med Chem; 2007 Jul; 50(15):3596-603. PubMed ID: 17580847
[TBL] [Abstract][Full Text] [Related]
3. Opioid receptor probes derived from cycloaddition of the hallucinogen natural product salvinorin A.
Lozama A; Cunningham CW; Caspers MJ; Douglas JT; Dersch CM; Rothman RB; Prisinzano TE
J Nat Prod; 2011 Apr; 74(4):718-26. PubMed ID: 21338114
[TBL] [Abstract][Full Text] [Related]
4. Salvinorin A, an active component of the hallucinogenic sage salvia divinorum is a highly efficacious kappa-opioid receptor agonist: structural and functional considerations.
Chavkin C; Sud S; Jin W; Stewart J; Zjawiony JK; Siebert DJ; Toth BA; Hufeisen SJ; Roth BL
J Pharmacol Exp Ther; 2004 Mar; 308(3):1197-203. PubMed ID: 14718611
[TBL] [Abstract][Full Text] [Related]
5. A unique natural selective kappa-opioid receptor agonist, salvinorin A, and its roles in human therapeutics.
Cruz A; Domingos S; Gallardo E; Martinho A
Phytochemistry; 2017 May; 137():9-14. PubMed ID: 28190678
[TBL] [Abstract][Full Text] [Related]
6. Neoclerodane diterpenes as a novel scaffold for mu opioid receptor ligands.
Harding WW; Tidgewell K; Byrd N; Cobb H; Dersch CM; Butelman ER; Rothman RB; Prisinzano TE
J Med Chem; 2005 Jul; 48(15):4765-71. PubMed ID: 16033256
[TBL] [Abstract][Full Text] [Related]
7. Synthetic studies of neoclerodane diterpenes from Salvia divinorum: selective modification of the furan ring.
Harding WW; Schmidt M; Tidgewell K; Kannan P; Holden KG; Dersch CM; Rothman RB; Prisinzano TE
Bioorg Med Chem Lett; 2006 Jun; 16(12):3170-4. PubMed ID: 16621556
[TBL] [Abstract][Full Text] [Related]
8. New neoclerodane diterpenoids isolated from the leaves of Salvia divinorum and their binding affinities for human kappa opioid receptors.
Lee DY; Ma Z; Liu-Chen LY; Wang Y; Chen Y; Carlezon WA; Cohen B
Bioorg Med Chem; 2005 Oct; 13(19):5635-9. PubMed ID: 16084728
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and in vitro pharmacological studies of new C(4)-modified salvinorin A analogues.
Lee DY; He M; Liu-Chen LY; Wang Y; Li JG; Xu W; Ma Z; Carlezon WA; Cohen B
Bioorg Med Chem Lett; 2006 Nov; 16(21):5498-502. PubMed ID: 16945525
[TBL] [Abstract][Full Text] [Related]
10. Synthetic studies of neoclerodane diterpenes from Salvia divinorum: role of the furan in affinity for opioid receptors.
Simpson DS; Lovell KM; Lozama A; Han N; Day VW; Dersch CM; Rothman RB; Prisinzano TE
Org Biomol Chem; 2009 Sep; 7(18):3748-56. PubMed ID: 19707679
[TBL] [Abstract][Full Text] [Related]
11. Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist.
Roth BL; Baner K; Westkaemper R; Siebert D; Rice KC; Steinberg S; Ernsberger P; Rothman RB
Proc Natl Acad Sci U S A; 2002 Sep; 99(18):11934-9. PubMed ID: 12192085
[TBL] [Abstract][Full Text] [Related]
12. Neuropharmacology of the naturally occurring kappa-opioid hallucinogen salvinorin A.
Cunningham CW; Rothman RB; Prisinzano TE
Pharmacol Rev; 2011 Jun; 63(2):316-47. PubMed ID: 21444610
[TBL] [Abstract][Full Text] [Related]
13. Modification of the furan ring of salvinorin A: identification of a selective partial agonist at the kappa opioid receptor.
Béguin C; Duncan KK; Munro TA; Ho DM; Xu W; Liu-Chen LY; Carlezon WA; Cohen BM
Bioorg Med Chem; 2009 Feb; 17(3):1370-80. PubMed ID: 19147366
[TBL] [Abstract][Full Text] [Related]
14. The hallucinogen derived from Salvia divinorum, salvinorin A, has kappa-opioid agonist discriminative stimulus effects in rats.
Willmore-Fordham CB; Krall DM; McCurdy CR; Kinder DH
Neuropharmacology; 2007 Sep; 53(4):481-6. PubMed ID: 17681558
[TBL] [Abstract][Full Text] [Related]
15. Studies toward the pharmacophore of salvinorin A, a potent kappa opioid receptor agonist.
Munro TA; Rizzacasa MA; Roth BL; Toth BA; Yan F
J Med Chem; 2005 Jan; 48(2):345-8. PubMed ID: 15658846
[TBL] [Abstract][Full Text] [Related]
16. Kappa-opioid receptor-selective dicarboxylic ester-derived salvinorin A ligands.
Polepally PR; White K; Vardy E; Roth BL; Ferreira D; Zjawiony JK
Bioorg Med Chem Lett; 2013 May; 23(10):2860-2. PubMed ID: 23587424
[TBL] [Abstract][Full Text] [Related]
17. Isolation and chemical modification of clerodane diterpenoids from Salvia species as potential agonists at the kappa-opioid receptor.
Li Y; Husbands SM; Mahon MF; Traynor JR; Rowan MG
Chem Biodivers; 2007 Jul; 4(7):1586-93. PubMed ID: 17638340
[TBL] [Abstract][Full Text] [Related]
18. Synthetic studies of neoclerodane diterpenes from Salvia divinorum: semisynthesis of salvinicins A and B and other chemical transformations of salvinorin A.
Harding WW; Schmidt M; Tidgewell K; Kannan P; Holden KG; Gilmour B; Navarro H; Rothman RB; Prisinzano TE
J Nat Prod; 2006 Jan; 69(1):107-12. PubMed ID: 16441078
[TBL] [Abstract][Full Text] [Related]
19. Potential anxiolytic- and antidepressant-like effects of salvinorin A, the main active ingredient of Salvia divinorum, in rodents.
Braida D; Capurro V; Zani A; Rubino T; Viganò D; Parolaro D; Sala M
Br J Pharmacol; 2009 Jul; 157(5):844-53. PubMed ID: 19422370
[TBL] [Abstract][Full Text] [Related]
20. Salvinorin A: from natural product to human therapeutics.
Vortherms TA; Roth BL
Mol Interv; 2006 Oct; 6(5):257-65. PubMed ID: 17035666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
